Anorexiants are used to treat obesity. Anorexiants suppress the appetite control and increases the basal metabolic rate of the individual.
In 2018, the global Anorexiants market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Anorexiants status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Anorexiants development in North America, Europe and Asia-Pacific.

The key players covered in this study

Akrimax Pharmaceuticals
Teva
Johnson & Johnson
Roche
Arena Pharmaceuticals
Novo Nordisk
Abbott
Epic Pharma
Recordati Rare Diseases

Market segment by Type, the product can be split into

Oral Anorexiants
Subcutaneous Anorexiants

Market segment by Application, split into

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Market segment by Regions/Countries, this report covers

North America
Europe
Asia-Pacific

The study objectives of this report are:

To analyze global Anorexiants status, future forecast, growth opportunity, key market and key players.
To present the Anorexiants development in North America, Europe and Asia-Pacific.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Anorexiants are as follows:
History Year: 2014-2018

Base Year:

2018

Estimated Year:

2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.